Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline

Leuconostoc lactis is a recognised cause of infection in immunocompromised hosts. It is intrinsically resistant to multiple antibiotics and treatment options may be limited. We report a case of safe and effective use of tigecycline in the treatment of Leuconostoc catheter-related line sepsis in a ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Trupti, Molloy, Aoife, Smith, Robin, Balakrishnan, Indran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892628/
https://www.ncbi.nlm.nih.gov/pubmed/24470945
http://dx.doi.org/10.4081/idr.2012.e31
_version_ 1782299558348324864
author Patel, Trupti
Molloy, Aoife
Smith, Robin
Balakrishnan, Indran
author_facet Patel, Trupti
Molloy, Aoife
Smith, Robin
Balakrishnan, Indran
author_sort Patel, Trupti
collection PubMed
description Leuconostoc lactis is a recognised cause of infection in immunocompromised hosts. It is intrinsically resistant to multiple antibiotics and treatment options may be limited. We report a case of safe and effective use of tigecycline in the treatment of Leuconostoc catheter-related line sepsis in a neutropenic patient. To our knowledge, this is the first reported case of successful use of tigecycline for Leuconostoc bacteremia.
format Online
Article
Text
id pubmed-3892628
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher PAGEPress Publications
record_format MEDLINE/PubMed
spelling pubmed-38926282014-01-27 Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline Patel, Trupti Molloy, Aoife Smith, Robin Balakrishnan, Indran Infect Dis Rep Case Report Leuconostoc lactis is a recognised cause of infection in immunocompromised hosts. It is intrinsically resistant to multiple antibiotics and treatment options may be limited. We report a case of safe and effective use of tigecycline in the treatment of Leuconostoc catheter-related line sepsis in a neutropenic patient. To our knowledge, this is the first reported case of successful use of tigecycline for Leuconostoc bacteremia. PAGEPress Publications 2012-04-27 /pmc/articles/PMC3892628/ /pubmed/24470945 http://dx.doi.org/10.4081/idr.2012.e31 Text en ©Copyright T. Patel et al., 2012 This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Licensee PAGEPress, Italy
spellingShingle Case Report
Patel, Trupti
Molloy, Aoife
Smith, Robin
Balakrishnan, Indran
Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title_full Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title_fullStr Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title_full_unstemmed Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title_short Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline
title_sort successful treatment of leuconostoc bacteremia in a neutropenic patient with tigecycline
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892628/
https://www.ncbi.nlm.nih.gov/pubmed/24470945
http://dx.doi.org/10.4081/idr.2012.e31
work_keys_str_mv AT pateltrupti successfultreatmentofleuconostocbacteremiainaneutropenicpatientwithtigecycline
AT molloyaoife successfultreatmentofleuconostocbacteremiainaneutropenicpatientwithtigecycline
AT smithrobin successfultreatmentofleuconostocbacteremiainaneutropenicpatientwithtigecycline
AT balakrishnanindran successfultreatmentofleuconostocbacteremiainaneutropenicpatientwithtigecycline

Ejemplares similares